Contraceptive Drugs Market Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Clinics, Online Channel, Public Channel and NGOs, and Others), and Region 2024-2032

Contraceptive Drugs Market Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Clinics, Online Channel, Public Channel and NGOs, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A6300
Buy Now

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Contraceptive Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Product
    6.1    Oral Contraceptive Pills
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Injectable Contraceptives
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Topical Contraceptives
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Age Group
    7.1    15–24 years
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    25–34 years
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    35–44 years
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Above 44 years
        7.4.1 Market Trends
        7.4.2 Market Forecast
8   Market Breakup by Distribution Channel
    8.1    Retail Pharmacy
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Hospital Pharmacy
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Clinics
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Online Channel
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Public Channel and NGOs
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Others
        8.6.1 Market Trends
        8.6.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    AbbVie Inc.
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Afaxys Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
        14.3.3    Agile Therapeutics
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
        14.3.4    Amneal Pharmaceuticals Inc.
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
        14.3.5    Bayer AG
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Johnson & Johnson 
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Mithra Pharmaceuticals SA
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
        14.3.8    Novartis AG
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Pfizer Inc. 
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Teva Pharmaceutical Industries Ltd.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Viatris Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials

List of Figures

Figure 1: Global: Contraceptive Drugs Market: Major Drivers and Challenges
Figure 2: Global: Contraceptive Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Contraceptive Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Contraceptive Drugs Market: Breakup by Product (in %), 2023
Figure 5: Global: Contraceptive Drugs Market: Breakup by Age Group (in %), 2023
Figure 6: Global: Contraceptive Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Contraceptive Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Contraceptive Drugs (Oral Contraceptive Pills) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Contraceptive Drugs (Injectable Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Contraceptive Drugs (Injectable Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Contraceptive Drugs (Topical Contraceptives) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Contraceptive Drugs (Topical Contraceptives) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Contraceptive Drugs (15–24 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Contraceptive Drugs (15–24 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Contraceptive Drugs (25–34 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Contraceptive Drugs (25–34 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Contraceptive Drugs (35–44 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Contraceptive Drugs (35–44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Contraceptive Drugs (Above 44 years) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Contraceptive Drugs (Above 44 years) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Contraceptive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Contraceptive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Contraceptive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Contraceptive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Contraceptive Drugs (Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Contraceptive Drugs (Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Contraceptive Drugs (Online Channel) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Contraceptive Drugs (Online Channel) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Contraceptive Drugs (Public Channel and NGOs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Contraceptive Drugs (Public Channel and NGOs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Contraceptive Drugs (Other Distribution Channels) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Contraceptive Drugs (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: North America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: North America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: United States: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: United States: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: Canada: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: Canada: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Asia-Pacific: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Asia-Pacific: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: China: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: China: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Japan: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Japan: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: India: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: India: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: South Korea: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: South Korea: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Australia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Australia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Indonesia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Indonesia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Europe: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Europe: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Germany: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Germany: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: France: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: France: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: United Kingdom: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: United Kingdom: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Italy: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Italy: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Spain: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Spain: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Russia: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Russia: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Latin America: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Latin America: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Brazil: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Brazil: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Mexico: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Mexico: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Others: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Others: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Middle East and Africa: Contraceptive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Middle East and Africa: Contraceptive Drugs Market: Breakup by Country (in %), 2023
Figure 82: Middle East and Africa: Contraceptive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Global: Contraceptive Drugs Industry: SWOT Analysis
Figure 84: Global: Contraceptive Drugs Industry: Value Chain Analysis
Figure 85: Global: Contraceptive Drugs Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Contraceptive Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Contraceptive Drugs Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: Contraceptive Drugs Market Forecast: Breakup by Age Group (in Million US$), 2024-2032
Table 4: Global: Contraceptive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Contraceptive Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Contraceptive Drugs Market: Competitive Structure
Table 7: Global: Contraceptive Drugs Market: Key Players

Contraceptive Drugs Market Report by Product (Oral Contraceptive Pills, Injectable Contraceptives, Topical Contraceptives), Age Group (15–24 years, 25–34 years, 35–44 years, Above 44 years), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Clinics, Online Channel, Public Channel and NGOs, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More